Related Experiment Video
Updated: Jul 7, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Enhancing generalizability and efficiency in clinical trials through dynamic information borrowing for both
1Department of Public Health, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
External information in clinical trials improves efficiency. Our study compared methods for borrowing information in both arms, finding specific priors suitable for low heterogeneity and test-then-pool for high heterogeneity.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Pharmaceutical Research
Background:
- External information enhances clinical trial validity and efficiency.
- Borrowing information in both experimental and control arms presents unique challenges.
- Existing research often focuses on control arm information borrowing only.
Purpose of the Study:
- To evaluate information borrowing methods in two-arm clinical trials.
- To compare the operating characteristics of test-then-pool, normalized power prior, calibrated power prior, and elastic prior methods.
- To identify optimal methods for different levels of data heterogeneity.
Main Methods:
- Applied four distinct information borrowing methods: test-then-pool, normalized power prior, calibrated power prior, and elastic prior.
- Utilized a two-arm information borrowing framework.
- Conducted simulation studies under most and least desirable scenarios of information borrowing.
Main Results:
- All methods controlled type I error rates within 5% in desirable scenarios.
- Normalized power prior, calibrated power prior, and elastic prior increased power to 95% in desirable scenarios.
- In least desirable scenarios, type I error rates exceeded 20% for these priors, with power decreasing to ~80%.
Conclusions:
- Normalized power prior, calibrated power prior, and elastic prior are effective with minimal data heterogeneity.
- The test-then-pool approach is a more robust choice when significant discrepancies exist between historical and current data.
- Findings guide the selection of appropriate information borrowing strategies in clinical trials.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Clinical Trials: Overview